Adjuvant therapy in pancreatic cancer

被引：33

作者：

Jones, Owain Peris ^{[1
]}

Melling, James Daniel ^{[1
]}

Ghaneh, Paula ^{[1
]}

机构：

[1] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool L69 3GA, Merseyside, England

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2014年 / 20卷 / 40期

关键词：

Pancreatic cancer; Adjuvant; Gemcitabine; Chemotherapy; Chemoradiotherapy; Phase III; RANDOMIZED CONTROLLED-TRIAL; PHASE-III TRIAL; CURATIVE RESECTION; RADIATION-THERAPY; FOLINIC ACID; REGIONAL HYPERTHERMIA; PERIAMPULLARY REGION; IMPROVED SURVIVAL; COOPERATIVE GROUP; PLUS GEMCITABINE;

D O I：

10.3748/wjg.v20.i40.14733

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic cancer remains one of the leading causes of cancer related death worldwide with an overall five-year survival of less than 5%. Potentially curative surgery, which alone can improve 5-year survival to 10%, is an option for only 10%-20% of patients at presentation owing to local invasion of the tumour or metastatic disease. Adjuvant chemotherapy has been shown to improve 5-year survival to 20%-25% but conflicting evidence remains with regards to chemoradiation. In this article we review the current evidence available from published randomised trials and discuss ongoing phase. trials in relation to adjuvant therapy in pancreatic cancer. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.

引用

页码：14733 / 14746

页数：14

共 56 条

[31] Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients [J].

Moody, John S. ;

Sawrie, Stephen M. ;

Kozak, Kevin R. ;

Plastaras, John P. ;

Howard, George ;

Bonner, James A. .

JOURNAL OF GASTROENTEROLOGY, 2009, 44 (01) :84-91

[32] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group [J].

Moore, Malcolm J. ;

Goldstein, David ;

Hamm, John ;

Figer, Arie ;

Hecht, Joel R. ;

Gallinger, Steven ;

Au, Heather J. ;

Murawa, Pawel ;

Walde, David ;

Wolff, Robert A. ;

Campos, Daniel ;

Lim, Robert ;

Ding, Keyue ;

Clark, Gary ;

Voskoglou-Nomikos, Theodora ;

Ptasynski, Mieke ;

Parulekar, Wendy .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :1960-1966

[33] Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and-3(v1) trials [J].

Neoptolemos, J. P. ;

Stocken, D. D. ;

Smith, C. Tudur ;

Bassi, C. ;

Ghaneh, P. ;

Owen, E. ;

Moore, M. ;

Padbury, R. ;

Doi, R. ;

Smith, D. ;

Buechler, M. W. .

BRITISH JOURNAL OF CANCER, 2009, 100 (02) :246-250

[34] Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial [J].

Neoptolemos, John P. ;

Stocken, Deborah D. ;

Bassi, Claudio ;

Ghaneh, Paula ;

Cunningham, David ;

Goldstein, David ;

Padbury, Robert ;

Moore, Malcolm J. ;

Gallinger, Steven ;

Mariette, Christophe ;

Wente, Moritz N. ;

Izbicki, Jakob R. ;

Friess, Helmut ;

Lerch, Markus M. ;

Dervenis, Christos ;

Olah, Attila ;

Butturini, Giovanni ;

Doi, Ryuichiro ;

Lind, Pehr A. ;

Smith, David ;

Valle, Juan W. ;

Palmer, Daniel H. ;

Buckels, John A. ;

Thompson, Joyce ;

McKay, Colin J. ;

Rawcliffe, Charlotte L. ;

Buechler, Markus W. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (10) :1073-1081

[35] Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:: a randomised controlled trial [J].

Neoptolemos, JP ;

Dunn, JA ;

Stocken, DD ;

Almond, J ;

Link, K ;

Beger, H ;

Bassi, C ;

Falconi, M ;

Pederzoli, P ;

Dervenis, C ;

Fernandez-Cruz, L ;

Lacaine, F ;

Pap, A ;

Spooner, D ;

Kerr, DJ ;

Friess, H ;

Büchler, MW .

LANCET, 2001, 358 (9293) :1576-1585

[36] A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer [J].

Neoptolemos, JP ;

Stocken, DD ;

Friess, H ;

Bassi, C ;

Dunn, JA ;

Hickey, H ;

Beger, H ;

Fernandez-Cruz, L ;

Dervenis, C ;

Lacaine, F ;

Falconi, M ;

Pederzoli, P ;

Pap, A ;

Spooner, D ;

Kerr, DJ ;

Büchler, MW .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1200-1210

[37] CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC) [J].

Neuhaus, P. ;

Riess, H. ;

Post, S. ;

Gellert, K. ;

Ridwelski, K. ;

Schramm, H. ;

Zuelke, C. ;

Fahlke, J. ;

Langrehr, J. ;

Oettle, H. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[38] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial [J].

Oettle, Helmut ;

Post, Stefan ;

Neuhaus, Peter ;

Gellert, Klaus ;

Langrehr, Jan ;

Ridwelski, Karsten ;

Schramm, Harald ;

Fahlke, Joerg ;

Zuelke, Carl ;

Burkart, Christof ;

Gutberlet, Klaus ;

Kettner, Erika ;

Schmalenberg, Harald ;

Weigang-Koehler, Karin ;

Bechstein, Wolf-Otto ;

Niedergethmann, Marco ;

Schmidt-Wolf, Ingo ;

Roll, Lars ;

Doerken, Bernd ;

Riess, Hanno .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03) :267-277

[39] Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031 [J].

Picozzi, V. J. ;

Abrams, R. A. ;

Decker, P. A. ;

Traverso, W. ;

O'Reilly, E. M. ;

Greeno, E. ;

Martin, R. C. ;

Wilfong, L. S. ;

Rothenberg, M. L. ;

Posner, M. C. ;

Pisters, P. W. T. .

ANNALS OF ONCOLOGY, 2011, 22 (02) :348-354

[40] Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma [J].

Picozzi, VJ ;

Kozarek, RA ;

Traverso, LW .

AMERICAN JOURNAL OF SURGERY, 2003, 185 (05) :476-480

← 1 2 3 4 5 6 →